Dr. Priyanka Singh | Nanobiotechnology Awards | Most Cited Paper Award

Posted on by ScienceFather

Dr. Priyanka Singh | Nanobiotechnology Awards | Most Cited Paper Award

Dr. Priyanka Singh , Denmark Technical University , Denmark

Dr. Priyanka Singh is a Senior Researcher at the Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark. With over seven years of post-doctoral experience, she specializes in green nanoscience and medical biology, focusing on innovative drug development for cancer and infections. Dr. Singh holds a Ph.D. in Nanoscience from Kyung Hee University and has secured substantial external funding for her pioneering research in nanomaterials. She is also committed to mentoring Ph.D. students and fostering interdisciplinary collaborations to advance cell biology and translate research into impactful outcomes.

Professional Profile:

Google Scholar

Education:

Dr. Priyanka Singh earned her Ph.D. in Nanoscience from Kyung Hee University, South Korea, in 2016, where she designed nanoparticles and drug conjugates/nanoformulations to enhance the pharmacokinetics of poorly water-soluble drugs for cancer and infectious cells. She holds a Diploma in Transformational Leadership Programme-Leading Women from CBS, Denmark, completed in November 2020. Dr. Singh has acquired several certifications from the University of Wisconsin–Madison, USA, including physiological characterization, solubilization, and solid form screening for drugs (2022), biologics (2021), drug development processes and CMC aspects (2021), and preclinical and phase 1 oral drug formulations (2021). Additionally, she completed a Teaching Lab course at DTU in January 2022, focused on university-level teaching and learning. Her academic background also includes a Master’s in Microbiology from CSJMU, India (2008-2010), and a Bachelor’s in Microbiology from Kachchh University, India (2005-2008).

Work Experience:

Dr. Priyanka Singh is a Senior Researcher at the Center for Biosustainability, Technical University of Denmark, since December 2023. She leads studies on developing nanomaterials for anticancer and antimicrobial drugs, publishing in high-impact journals, and supervises Ph.D. students in hands-on development of these materials. She is also leading a project on “graphene-based solutions for marine biofilm inhibition” and employs advanced techniques like Flow cytometry, SEM, TEM, and Incucyte for characterizing nanomaterials in various disease models. From January 2021 to November 2023, as a Researcher at the same center, she led a team advancing nanomaterials in medical applications, focusing on biologics formation and characterization, investigating their impact on cancer cells, and enhancing their therapeutic potential.

Publication Top  Notes: